Live Breaking News & Updates on Animal Pharmaceuticals Market|Page 5

Companion Animal Pharmaceuticals Market worth $18.5 billion by 2026 - Exclusive Report by MarketsandMarkets
Companion Animal Pharmaceuticals Market
by Indication (Infectious Diseases, Antibiotics, Parasiticides, Vaccines, Pain), Animal Type (Dogs, Cats, Horses), Distribution Channel (Veterinary Hospitals & Clinics), COVID-19 Impact - Global Forecast to 2026 , published by MarketsandMarkets, the global market is projected to reach USD 18.5 billion by 2026 from USD 12.8 billion in 2021, at a CAGR of 7.6% during the forecast period.
Browse in-depth TOC on Companion Animal Pharmaceuticals Market
143 - Tables
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252218886
The growth in this market is majorly driven by the growth in companion animal ownership, rising prevalence of zoonotic diseases, rising demand for pet insurance with the growing animal health expenditure, and initiatives by various government agencies and animal as ....

United States , United Kingdom , Boehringer Ingelheim Gmb , Kostenloser Wertpapierhandel , Asia Pacific , Ceva Sant , Ringpu Bio , Aashish Mehra , Indian Immunologicals Ltd , Endovac Animal Health , Investments Limited India , Animal Health Group , Elanco Animal Health Incorporated , Zydus Animal Health , Devices Market Research Reports Consulting , Dechra Pharmaceuticals , Merck Co Inc , Norbrook Holdings Limited United Kingdom , Research Insight , Companion Animal Pharmaceuticals Market , Technology Co Ltd , Zoetis Inc , Animal Pharmaceuticals Market , Infectious Diseases , Animal Type , Distribution Channel ,